Impact of influenza vaccination in the Netherlands, 2007-2016: Vaccinees consult their general practitioner for clinically diagnosed influenza, acute respiratory infections, and pneumonia more often than non-vaccinees.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 10 06 2020
accepted: 26 03 2021
entrez: 28 5 2021
pubmed: 29 5 2021
medline: 13 10 2021
Statut: epublish

Résumé

We aimed to develop an innovative population-based method to estimate the health effect of influenza vaccination based on electronic medical records collected within a general practitioner (GP)-based influenza surveillance system in the Netherlands. In each season between 2006/07 and 2015/16, we fitted multilevel Poisson regression models to compare GP consultation rates for clinically diagnosed influenza, acute respiratory infections (ARI), pneumonia, and lower back pain (as a control) between vaccinated vs. unvaccinated individuals. Season-specific relative risks and 95% confidence intervals (CI) were pooled into summary risk ratio (SRR) through random-effects meta-analysis models. Analyses were stratified by patient age (<45, 45-59, 60-74, ≥75 years) and medical indication for the vaccine (any vs. none, subjects aged ≤60 years only). Overall, 12.6% and 21.4% of study subjects were vaccinated because of their age only or because of an underlying medical condition. Vaccine uptake declined over time, especially among subjects aged ≤74 years with medical indications for vaccination. Vaccinated individuals had significantly higher GP consultation rates for clinically diagnosed influenza (SRR 1.24, 95% CI 1.12-1.38, p-value <0.001), ARI (SRR 1.33, 95% CI 1.27-1.39, p-value <0.001), pneumonia (SRR 1.27, 95% CI 1.19-1.36, p-value <0.001), and lower back pain (SRR 1.21, 95% CI 1.14-1.28, p-value <0.001) compared to unvaccinated individuals. Contrary to expectations, influenza vaccinees have GP consultation rates for clinically diagnosed influenza, ARI and pneumonia that are 24-33% higher compared to unvaccinated individuals. The lower back pain finding suggests that the increase in consultation rates is partially caused by confounding. Importantly, considering the data are not laboratory-confirmed, our results cannot be linked directly to influenza, but only to respiratory illnesses in general.

Identifiants

pubmed: 34048429
doi: 10.1371/journal.pone.0249883
pii: PONE-D-20-17695
pmc: PMC8162646
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0249883

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

PLoS One. 2018 Jul 17;13(7):e0200813
pubmed: 30016348
Clin Infect Dis. 2012 Jun;54(12):1778-83
pubmed: 22423139
Vaccine. 2017 Aug 24;35(36):4796-4800
pubmed: 28818471
Balkan Med J. 2018 Jan 20;35(1):77-83
pubmed: 28903887
Lancet Respir Med. 2019 Jan;7(1):69-89
pubmed: 30553848
PLoS One. 2018 Apr 9;13(4):e0195305
pubmed: 29630633
Stat Med. 2002 Feb 28;21(4):589-624
pubmed: 11836738
BMC Public Health. 2019 May 6;19(1):512
pubmed: 31060532
Vaccines (Basel). 2018 May 21;6(2):
pubmed: 29883414
Stat Med. 2002 Jun 15;21(11):1539-58
pubmed: 12111919
Lancet Infect Dis. 2016 Aug;16(8):942-51
pubmed: 27061888
BMC Med. 2019 Jan 10;17(1):9
pubmed: 30626399
Vaccine. 2018 Feb 28;36(10):1272-1278
pubmed: 29402578
PLoS One. 2017 Jan 9;12(1):e0169528
pubmed: 28068386
J Infect Dis. 2017 Aug 15;216(4):415-424
pubmed: 28931240
Vaccine. 2018 Apr 5;36(15):1958-1964
pubmed: 29525279
Euro Surveill. 2019 Nov;24(48):
pubmed: 31796152
Vaccine. 2020 Apr 9;38(17):3397-3403
pubmed: 31859200
J Infect. 2017 Nov;75(5):381-394
pubmed: 28935236
Hum Vaccin Immunother. 2018 Mar 4;14(3):724-735
pubmed: 28481673
Lancet Respir Med. 2017 Mar;5(3):200-211
pubmed: 28189522
Euro Surveill. 2013 Sep 12;18(37):
pubmed: 24079398
BMC Med. 2013 Jun 25;11:153
pubmed: 23800265
Clin Infect Dis. 2019 Apr 24;68(9):1444-1453
pubmed: 30307490
J Infect Dis. 2017 Aug 15;216(4):405-414
pubmed: 28931244

Auteurs

Saverio Caini (S)

Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.

John Paget (J)

Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.

Peter Spreeuwenberg (P)

Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.

Joke C Korevaar (JC)

Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.

Adam Meijer (A)

National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.

Mariëtte Hooiveld (M)

Nivel (Netherlands Institute for Health Services Research), Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH